Trevi Therapeutics, Inc.
NEW HAVEN, CT · Founded 2011 · CIK 0001563880 · Medtech · Public
Haduvio, an oral extended-release nalbuphine formulation for chronic cough treatment
trevitherapeutics.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $118M
- 5 Form D · Apr 2022
- 54 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201220142016201820202022
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $6,564,102 | |
| Private capital raised | Form D · SEC | $41,148,460 | |
| Private capital raised | Form D · SEC | $11,819,891 | |
| Private capital raised | Form D · SEC | $3,000,000 | |
| Private capital raised | Form D · SEC | $54,999,998 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1729 | Nicolaos Christodoulides | — | — |
| 1730 | SURGISENSE CORPORATION | — | — |
| 1731 | Sera Prognostics | — | $150M |
| 1732 | Trevi Therapeutics, Inc. | — | $118M |
| 1733 | EPOULOSIS THERAPEUTICS, INC. | — | — |
| 1734 | ANDE Corp | — | $109M |
| 1735 | PAIGE.AI, Inc. | — | $108M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Mette AggerDirector
- James CassellaDirector
- Dominick ColangeloDirector
- Lisa DelfiniExecutive Officer
- Cayce DentonDirector
- William ForbesExecutive Officer
- Jennifer GoodDirector · Executive Officer
- Michael HeffernanDirector
- Ed MathersDirector
- Edward MathersDirector
- David MeekerDirector
- Annie MitsakDirector
- Eran NadavDirector
- Thomas SciasciaExecutive Officer
- Chris SeiterExecutive Officer
- Joseph SorrentinoExecutive Officer
- Otello StampacchiaDirector
- Anne VanLentDirector
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.